Google TrendROB LOWE (1000+) — Daily Wire's 'Confession': Details Revealed For James Franco, Rob Lowe Film
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Current Targeted Therapy" (30 stories)

Top Headline Story

Aging and cancer: current understandings and future perspectives
Lead StoryNatureworld
Jul 8

Aging and cancer: current understandings and future perspectives

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE10al82QjlzMDRJb1U5b1hDbkFkTWxyVFJ6Um1ubDlMTjRYOXM3T2I5RGkwNFRCMjYtS3FvbVFlY1VMeWdRekYyUGhQVks3U2tiUWdoOUlWaHZfSEpIZzh3?oc=5" target="_blank">Aging and cancer: current understandings and future perspectives</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
1000+24m ago

rob lowe

Daily Wire's 'Confession': Details Revealed For James Franco, Rob Lowe Film

500+24m ago

tanner hudson

Bengals tight end Tanner Hudson out for season with torn pec

1000+34m ago

payton pritchard

Celtics to extend guard Payton Pritchard on 2-year, $44.2M deal

500+34m ago

huevo

Ministerio de Agricultura realiza primera Mesa Técnica del Huevo para abordar desafíos del sector

Search Results for "Current Targeted Therapy"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
How Are Targeted Therapies Currently Used in Pediatric Brain Tumors?
ASCO Daily Newstech

How Are Targeted Therapies Currently Used in Pediatric Brain Tumors?

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPSVpnczZPM0pxaTdYS1h2M2lYVm5ldEo1ZmR6OFZNVVZDenFqVnlYUW5MSUlZOXh1eUZzSGdSTmpMWHFwa1BXS2FMcDJVQmxjRDc4OFpUSVc0UVQzUzE3TFdwQ1FmZVF5UndmSFVJdEl1clN6MDI0dklsOGVpal9qRWpFSDRmQ2VVOGVGS01CYWFBcW94?oc=5" target="_blank">How Are Targeted Therapies Currently Used in Pediatric Brain Tumors?</a>  <font color="#6f6f6f">ASCO Daily News</font>

Complement-targeted therapies for transplant-associated thrombotic microangiopathy: recent advances
Frontiersgeneral

Complement-targeted therapies for transplant-associated thrombotic microangiopathy: recent advances

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQQ1FJNHd4OHJuZUIxVWFZLWZoWDV1Umxjd19WZ005WUR0b3hzZmNySXJ0emY1QXZUNDRjcjB0NmpVaERlV25WWXZqY0E0aFpSb0tpblZQNW52blRDVFNmSXF0QkNobGlBcVlMRjBqR3RoRWgxSXVZUHExQlRWQkFTZV9JOVUxX3c4TDJTLWVlSFpSakFM?oc=5" target="_blank">Complement-targeted therapies for transplant-associated thrombotic microangiopathy: recent advances</a>  <font color="#6f6f6f">Frontiers</font>

CAR T cell therapy beyond cancer: current status, challenges and future prospects
Naturegeneral

CAR T cell therapy beyond cancer: current status, challenges and future prospects

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE43WVRRMkY3elBIcnp0TUJpV01HNEpabVNXcDY0WldTN3NEbk1faDNmWDdCdHVBNGtkOHlveVJwMnJ3b0dURUVvWV9rLVBKUzhsOVpmVU5LQ2tBNTA5ZVpN?oc=5" target="_blank">CAR T cell therapy beyond cancer: current status, challenges and future prospects</a>  <font color="#6f6f6f">Nature</font>

Ummul Asfeen: Current Progress and Future Directions in NSCLC Targeted Therapy
Oncodailygeneral

Ummul Asfeen: Current Progress and Future Directions in NSCLC Targeted Therapy

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE1zQlRYc0pyREFnNHhxekItdVF0OGtsYVdYcldNbkpxYTFiUG9xZE9FdWpLNHVfQUZLOU5wSmlORWpjMUlnWUlhM240M2VETnUzaE5LSnQ4eEk2VWxq?oc=5" target="_blank">Ummul Asfeen: Current Progress and Future Directions in NSCLC Targeted Therapy</a>  <font color="#6f6f6f">Oncodaily</font>

Current Targeted Therapy Options in ROS1-Positive NSCLC
Pharmacy Timesgeneral

Current Targeted Therapy Options in ROS1-Positive NSCLC

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNbkdGT1RlTmVqdGtGSW1kV21UeWhQcG1vV2Q5eEttSFlOZElIYmNCdG16UW1pOExNeHA3WFFhV29EVWdEemhpS3h1dHpCQThMMmhxSUJfVmhfS3gtQS1KLVR6RGVhUG9mbmQwMFYzZFZtMDE0Rmw1bVJ1Wkl2cHcwVmRaS1FGaEtBNVBKYlNQeUxZemd6?oc=5" target="_blank">Current Targeted Therapy Options in ROS1-Positive NSCLC</a>  <font color="#6f6f6f">Pharmacy Times</font>

Innate immunity: current understandings and future perspectives
Natureworld

Innate immunity: current understandings and future perspectives

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE4zR19vNG9tWlo3aUc1TzNjaW5xNVhkbEgzekJMR2lOM1p4UkI4QmNoQThSZzR5a0liODdiYU0tcjhCUktKajBoTWNHcUZsdWt4dGd4VjNtcW03V0piTGpZ?oc=5" target="_blank">Innate immunity: current understandings and future perspectives</a>  <font color="#6f6f6f">Nature</font>

Beyond the blockade: unmet needs in systemic targeted atopic dermatitis therapy
Frontiersworld

Beyond the blockade: unmet needs in systemic targeted atopic dermatitis therapy

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPVmxQbVh0NnpUT1A1REdSWDNEUDhfdVZSUWtKOWREZTBLeVdHYlpqbjlFUnU4TTd3OUoxdXJ6RmE2bmtkMGZKa1VSUXZiNFp4Nnc2Vjh0d0pfVVNaWmJEMjRkakdTTmc5ZTkwOUFsUXp6eFlCbXhKTy1ncFAzV21ySThQOHlTSjc1Rk41NmRCWjJFQQ?oc=5" target="_blank">Beyond the blockade: unmet needs in systemic targeted atopic dermatitis therapy</a>  <font color="#6f6f6f">Frontiers</font>

New Treatment Approaches for Triple-Negative Breast Cancer
ASCO Publicationsgeneral

New Treatment Approaches for Triple-Negative Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTE5WSFpoNUJXempwZmRNOW96ZzNmZ2hJWTVkeVFhNm1lbFNkLVhKUnFXZ3NMZm5OdjI0cmxta282ODd6MEVxY0FNZW5NTEh2dDJpazVuX21WUVVIZW8?oc=5" target="_blank">New Treatment Approaches for Triple-Negative Breast Cancer</a>  <font color="#6f6f6f">ASCO Publications</font>

Microbiota in cancer: current understandings and future perspectives
Natureworld

Microbiota in cancer: current understandings and future perspectives

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5YV216TG5rWVBzU05VMWNrSmJlVElzMWxWZThwNWdTWXZOVkVUZGxYSU53V2tmM0JQMVE4bzdWdzhnYW80cWtpVmFQUl9ZV3BIQ3hjT0t2OU8ydEhfMWo4?oc=5" target="_blank">Microbiota in cancer: current understandings and future perspectives</a>  <font color="#6f6f6f">Nature</font>

HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future
Frontiersgeneral

HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPeEhoRER0Z0dRNFVXb0VJZTZmRVdETlFxMEEyWXlOMkV0SW1RdHgwX1JCMWRmWkdwY2tSWXc5aXFBRlJXSllmVm5nU1BBMmFyeTRqY2hjSkZWcnVVSVB2cHMzZEZqSDBYSWhzM2NEaTFBMDZ4MnFaakxXQUtIaEdCTFRIVjZYTzNQTVJaRmJTamJIQjNf?oc=5" target="_blank">HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future</a>  <font color="#6f6f6f">Frontiers</font>

KRAS-targeted therapies in colorectal cancer: a systematic analysis of mutations, inhibitors, and clinical trials
Naturegeneral

KRAS-targeted therapies in colorectal cancer: a systematic analysis of mutations, inhibitors, and clinical trials

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1pdWRwSUN0Ykw5ZU50QUZqenhsTmZhTmYyN2l5X2QzUmEtSDRoaDZtQ0hweWl6WFpOZ0o3MVBDbFZSVHZJdHhpNGFLQ3pVWmtjVGdxa0o0aHNxN3BYTm53?oc=5" target="_blank">KRAS-targeted therapies in colorectal cancer: a systematic analysis of mutations, inhibitors, and clinical trials</a>  <font color="#6f6f6f">Nature</font>

Targeted therapies in lung cancer: personalizing treatment across the age spectrum
Frontiersworld

Targeted therapies in lung cancer: personalizing treatment across the age spectrum

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxORktvLUJWekh1cEFkTDUxZjdmUm5ZLUl2c29GS2NubVdJb2szUnQ2eGtMN3FCc3JTNzEwY3Rxem9yQmtXOEFSUGJxc0dIU1JiYkhkMmttNXMyeWN6MGY3SWktT3dGOVFXbk5Ldm84VzN3ZXlzUkVKUVFaYTFsU19rcGtDVlZ3cExiV3JMekJn?oc=5" target="_blank">Targeted therapies in lung cancer: personalizing treatment across the age spectrum</a>  <font color="#6f6f6f">Frontiers</font>

Acute pancreatitis: mechanisms and therapeutic approaches | Signal Transduction and Targeted Therapy
Naturegeneral

Acute pancreatitis: mechanisms and therapeutic approaches | Signal Transduction and Targeted Therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE83ZTB1Y2lmblJoYmFTc09SRlo1czBldHlPN0xJSGl5WFpCVm85YmNMbGZveEFLYTB3ZDBPRUppaHpqVjZhZzJpYTk2WUR3cHJTc0JlV1dVaVJYalZFOUtv?oc=5" target="_blank">Acute pancreatitis: mechanisms and therapeutic approaches | Signal Transduction and Targeted Therapy</a>  <font color="#6f6f6f">Nature</font>

Glioblastoma at the crossroads: current understanding and future therapeutic horizons
Natureworld

Glioblastoma at the crossroads: current understanding and future therapeutic horizons

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0zRHhsNTNpNzgtdlJNLUxJNXVHdFdGSWVEUEhGbHdOUFNUakpKSS1BYkJvNDBQa1Y4SDNCUE02eFhXUVhIalc1Z1daNGxDcmtZVWdnZ1pMeFBMRWxOajZv?oc=5" target="_blank">Glioblastoma at the crossroads: current understanding and future therapeutic horizons</a>  <font color="#6f6f6f">Nature</font>

From bench to bedside: current development and emerging trend of KRAS-targeted therapy
Naturegeneral

From bench to bedside: current development and emerging trend of KRAS-targeted therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBHVDhobEdwTEVINmtLSlN2X0huc0haQy16VGJGSlhCRkg2cHBQcmJZNWxPZnVkTDNnMHJUNTRBbGE5Wl94OHdjZmF5NElhLWo2Q2xJRG1lUTZZenUyMGhv?oc=5" target="_blank">From bench to bedside: current development and emerging trend of KRAS-targeted therapy</a>  <font color="#6f6f6f">Nature</font>

First-line treatment for CLL in the era of targeted therapy - Blood Cancer Journal
Naturegeneral

First-line treatment for CLL in the era of targeted therapy - Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBEci1jdEl6bUliOXZEa2hSRW42U09OSnNTZ2toR2xqVjlBLXdIeEQ1cWMwXzRwUktLNmdaTGlhXzY1WTFqcUR1Ung2d2ItZE11UXloU0ZUQlZqai1XaGl3?oc=5" target="_blank">First-line treatment for CLL in the era of targeted therapy - Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

New approaches to targeted drug therapy of intracranial tumors - Cell Death Discovery
Naturegeneral

New approaches to targeted drug therapy of intracranial tumors - Cell Death Discovery

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9MM01iYXpPT0tmR2lxTnhEZ2xYSElXRi1NY241TjZrSUFEempjd2tzWVVDY1pVeDloOE1fVV94QXgtc3d6bTFaTUlHenFNVDdyNFZOMFVOMmdneEpfRWs0?oc=5" target="_blank">New approaches to targeted drug therapy of intracranial tumors - Cell Death Discovery</a>  <font color="#6f6f6f">Nature</font>

Targeted therapy for head and neck cancer: signaling pathways and clinical studies
Naturegeneral

Targeted therapy for head and neck cancer: signaling pathways and clinical studies

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1uNDVSUmVTdnNLV1dyUW1WNHQwM0hmejVVSXRUVUdPc2pzdU5jVldieWVMSm5kX2l6alNVUzdsNHQ5d1RMdFYxeXY4Z2RQMmFsWXNJZjA4Umh1bVRjS25J?oc=5" target="_blank">Targeted therapy for head and neck cancer: signaling pathways and clinical studies</a>  <font color="#6f6f6f">Nature</font>

Breast cancer: pathogenesis and treatments - Signal Transduction and Targeted Therapy
Naturegeneral

Breast cancer: pathogenesis and treatments - Signal Transduction and Targeted Therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE95bDk0RHlwY3cyOFF2ZzVkNHpRSFREaHNPWEc3VHM2SnhXcjhvMThDekxGYXFYTHpiaWtRbmRyTDJFSUZZOEd4YUZpTC1Jb21SNEhDMlFEaVpyb3NsSVQ0?oc=5" target="_blank">Breast cancer: pathogenesis and treatments - Signal Transduction and Targeted Therapy</a>  <font color="#6f6f6f">Nature</font>

Advances in molecular pathology and therapy of non-small cell lung cancer | Signal Transduction and Targeted Therapy
Natureworld

Advances in molecular pathology and therapy of non-small cell lung cancer | Signal Transduction and Targeted Therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TT3dtTFZkZ1c2ZXZCTUFZampCMzV4UFRLVDBEVXNpeUdNUmV5UjIzNmVZRWR3c3NtQ0dNRlN3NjJobGZnNWptNmRHWXpOMExaMHhUdW1Xem5EbDgwRWsw?oc=5" target="_blank">Advances in molecular pathology and therapy of non-small cell lung cancer | Signal Transduction and Targeted Therapy</a>  <font color="#6f6f6f">Nature</font>

Current Targeted Therapy Options in the Treatment of Cholangiocarcinoma: A Literature Review
The Cureus Journal of Medical Sciencegeneral

Current Targeted Therapy Options in the Treatment of Cholangiocarcinoma: A Literature Review

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxNZlhXM2JHVFk2Z0JidW5KSlNtUy1VWVZLOWlQTVF0aFZJZlkyVE5kTU9Oa0NJc0tFczVnQ3dGamFBbVJXTUJnRVNzaEQ0ZlJlTEliUWh5aW5WM0YwTnBITjhQcEpLYlhsWU1Qb2hkQUFYbC1vRVZUU1JTTkJRUE12RVd4b2ZGaGtpU2lJVi1Hd0d2aGtuZW8xM2hUODZkYlkwSzlVc294cXRiUktRcnRROVFVVV9tMG52VzZydzZCQzM3d1lNaDNCeQ?oc=5" target="_blank">Current Targeted Therapy Options in the Treatment of Cholangiocarcinoma: A Literature Review</a>  <font color="#6f6f6f">The Cureus Journal of Medical Science</font>

Landscape of targeted therapies for lung squamous cell carcinoma
Frontiersworld

Landscape of targeted therapies for lung squamous cell carcinoma

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOaEt5cEJjWnQ4UTJBS083Y04tbmVBbnZ2cjVnLUlTWm5UcnRja1JJWGJleXZmaUczUWJBMWl6bkRtNjB6WVlfUEhRUUk5eUJLd3JmYldmODhPdVFFeU5vTlRaZklfZzdESDI1dzM2WkxwS2pkN0J1R1RkLW51S3poOEpNcDZtYjlVenJtajZR?oc=5" target="_blank">Landscape of targeted therapies for lung squamous cell carcinoma</a>  <font color="#6f6f6f">Frontiers</font>

Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges
Naturegeneral

Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE11TUZkUl9zc2I5VDIxcVR3Qm9WTDBTdVdjUmRYc3k5UEVrdFNWOEpRUU1hSUFnWmZrU0NvTkd5WXJuYnF5b08xd0dmV09HZEtfZHQ5d19oVUY3SHZVY0lF?oc=5" target="_blank">Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges</a>  <font color="#6f6f6f">Nature</font>

Oncolytic virotherapy: basic principles, recent advances and future directions
Naturegeneral

Oncolytic virotherapy: basic principles, recent advances and future directions

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE80WVZiZTBIdHVWVkdZWUl6OXpELU5xUzdnbW0weFRqUHBCcVFyMHpiOElDdXd1NVpGcFpEQjZ3VF9hcDIzR1UzaHpOdVVJTzc5anhXRm1NMWdoRXVNcDRB?oc=5" target="_blank">Oncolytic virotherapy: basic principles, recent advances and future directions</a>  <font color="#6f6f6f">Nature</font>

Perspectives on cancer therapy—synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges
Naturetech

Perspectives on cancer therapy—synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5pWGZ6N25aYTNsSE9TNlAtMmJDT1JZNEhBcmtRR0k5WGw4UDlmRjJPX3RRSUdFX21iM0VueUlLVmQwZXZnT0NNSjB0MlZMX3o5RkpvTkt3YTcwd1VSUTBB?oc=5" target="_blank">Perspectives on cancer therapy—synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges</a>  <font color="#6f6f6f">Nature</font>

Genomic landscape and precision therapy in prostate cancer: current status and future directions
Naturegeneral

Genomic landscape and precision therapy in prostate cancer: current status and future directions

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5fSDU4UTEzZFNKSFlvWmxFbnJOSF9RNHk3SC1vanU5VEZqNGw0eXRCM2JaUElRZ2RFQlVnT05YanAycGZZejNfS3k2MUk0Y3h2bTEtbFlhNHM5RlljYjlV?oc=5" target="_blank">Genomic landscape and precision therapy in prostate cancer: current status and future directions</a>  <font color="#6f6f6f">Nature</font>

Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives
Frontiersworld

Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxPc1pKRmZUMWR0UmJ1QXpHMzdkSHNjMFZnZ3Q1TTcybktYV0xlQldGNmJUTUVsanVqajcwMG9IRFFtVEFFQ3A3Tm9KYXROUTh1d1h4YUFVY1VsTi0tVWZ6WWVzR0RyejVvVXl6dVFaNDdrVVZ3MU1aLXhXdVRXbXJ4MkdndjdyUXRNSUtiQzZZcFdxZ3ZC?oc=5" target="_blank">Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives</a>  <font color="#6f6f6f">Frontiers</font>

Immunotherapy for glioblastoma: current state, challenges, and future perspectives | Cellular & Molecular Immunology
Natureworld

Immunotherapy for glioblastoma: current state, challenges, and future perspectives | Cellular & Molecular Immunology

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBPMDY0TE9oUGo2LWpvckR1M2pTdGJ2UHB1dGhnNUNUNXYzYW5nWDhpTVd3bGxRLWZDY1NhaGx6TGtRUnFRWWxlMlFYeC1zTWc0c3hVZzB2RlRTc3Nzendz?oc=5" target="_blank">Immunotherapy for glioblastoma: current state, challenges, and future perspectives | Cellular & Molecular Immunology</a>  <font color="#6f6f6f">Nature</font>

Digestive cancers: mechanisms, therapeutics and management
Naturegeneral

Digestive cancers: mechanisms, therapeutics and management

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5IdFNfNDcxRXJaMFM4NnJVS2NUZmNzWmZIdy1MWTF0SnRzZ3llZ3dydmI0OUdPMk55RTNNcUVmWkwtVXFFV0VyOEZCbVFPWVhpRmNlQ3JYVnhfRDl6M19J?oc=5" target="_blank">Digestive cancers: mechanisms, therapeutics and management</a>  <font color="#6f6f6f">Nature</font>

"Current Targeted Therapy" — Live Google News Trends & Headlines